|
市場調査レポート
商品コード
1781119
アジア太平洋地域のフローサイトメトリー市場:分析・予測 (2025-2035年)Asia-Pacific Flow Cytometry Market: Analysis and Forecast, 2025-2035 |
||||||
カスタマイズ可能
|
アジア太平洋地域のフローサイトメトリー市場:分析・予測 (2025-2035年) |
出版日: 2025年07月31日
発行: BIS Research
ページ情報: 英文 51 Pages
納期: 1~5営業日
|
アジア太平洋地域のフローサイトメトリーの市場規模は、2024年の7億4,770万米ドルから、堅調な成長軌道にあり、2035年には19億1,960万米ドルに成長すると予測されています。
アジア太平洋地域では、フローサイトメトリーが重要な分析手法として注目されており、懸濁液中の個々の細胞を多項目にわたって包括的に解析することが可能になっています。この技術は、同地域の学術研究、医薬品開発、臨床診断の分野でますます重要性を増しています。がん研究、免疫学、感染症研究においては、イムノフェノタイピング、細胞周期解析、バイオマーカー検出といった主要な応用が頻繁に用いられています。
主要市場統計 | |
---|---|
予測期間 | 2025-2035年 |
2025年評価 | 8億810万米ドル |
2035年予測 | 19億1,960万米ドル |
CAGR | 9.04% |
同市場の急速な拡大は、特に韓国、日本、中国、インドといった国々において、スペクトルフローサイトメトリーやハイスループット技術の利用が進んでいることによって促進されています。試薬技術やデータ解析システムの進歩により、精度や運用効率もさらに向上しています。また、精密診断、細胞・遺伝子治療、個別化医療への関心の高まりも需要を加速させています。
フローサイトメトリーは、先進国・新興国の双方で医療インフラが強化される中で、トランスレーショナルリサーチや標的治療の計画に不可欠なツールとなりつつあります。同地域における精密医療やライフサイエンスのエコシステムが発展するにつれ、その重要性はますます高まり、不可欠な促進要素としての地位を築いています。
地域区分:
アジア太平洋
当レポートでは、アジア太平洋地域のフローサイトメトリーの市場を調査し、主要動向、市場影響因子の分析、法規制環境、技術・特許の分析、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。
範囲と定義
This report can be delivered in 2 working days.
Introduction to Asia-Pacific Flow Cytometry Market
The Asia-Pacific flow cytometry market, valued at $747.7 million in 2024, is on a robust growth trajectory and is anticipated to reach $1,919.6 million by 2035. In the APAC region, flow cytometry has emerged as a significant analytical method, allowing for complete multiparametric examination of individual cells in suspension. It is becoming more and more significant in academic research, pharmaceutical development, and clinical diagnostics throughout the region. In oncology, immunology, and infectious disease research, key applications like immunophenotyping, cell cycle analysis, and biomarker detection are frequently employed.
KEY MARKET STATISTICS | |
---|---|
Forecast Period | 2025 - 2035 |
2025 Evaluation | $808.1 Million |
2035 Forecast | $1,919.6 Million |
CAGR | 9.04% |
Rapid market expansion is being facilitated by the increasing use of spectral flow cytometry and high-throughput technologies, especially in nations like South Korea, Japan, China, and India. Accuracy and operating efficiency are being further improved by developments in reagent technologies and data analysis systems. Demand is also being accelerated by the growing emphasis on precision diagnostics, cell and gene treatments, and personalized medicine.
Flow cytometry is becoming an essential tool for translational research and targeted treatment planning as the healthcare infrastructure in both developed and emerging APAC markets gets stronger. As the region's precision medicine and life sciences ecosystem develops, its growing importance places it as a crucial facilitator.
Market Introduction
The market for APAC flow cytometry (FCM) is expanding rapidly due to rising demand in biomedical research, clinical diagnostics, and biopharmaceutical production. Flow cytometry is frequently used in cell cycle research, immunophenotyping, and biomarker development because it allows for quick, high-resolution study of individual cells. Research on autoimmune disorders, infectious diseases, and oncology is using it more and more in the area.
Technological developments including spectral flow cytometry, high-throughput, compact devices, and AI-based data interpretation tools are propelling the industry. Adoption is increasing in nations like China, India, Japan, and South Korea as a result of escalating research funding, benevolent government policies, and growing healthcare demands. Additionally, flow cytometry is becoming more popular in cutting-edge fields including vaccine development, regenerative medicine, and precision medicine.
Continuous advancements in laboratory capacity and healthcare accessibility are assisting in the removal of obstacles including high equipment costs, a shortage of qualified personnel, and infrastructure gaps that still exist in some emerging economies. Furthermore, partnerships between commercial companies and academic institutions are speeding up market penetration and innovation. The market for APAC flow cytometry is expected to continue growing and changing over the next several years due to an increase in the prevalence of disease and a greater emphasis on sophisticated diagnostics.
Regional Segmentation
Asia-Pacific
APAC Flow Cytometry Market Trends, Drivers and Challenges
Market Trends
Key Market Drivers
Major Challenges
How can this report add value to an organization?
Product/Innovation Strategy: The APAC flow cytometry market analysis provides insights into evolving research and clinical needs, enabling organizations to develop customized flow cytometry instruments, reagents, and software solutions that address specific requirements such as high-parameter analysis, spectral capabilities, or streamlined workflows for clinical diagnostics.
Growth/Marketing Strategy: The report helps organizations implement targeted marketing strategies tailored to key segments such as academic research, immuno-oncology, or infectious disease diagnostics and specific regional opportunities, improving customer engagement and accelerating adoption.
Competitive Strategy: Organizations can differentiate their flow cytometry offerings by emphasizing features particularly valued by end-users in target regions, such as instrument scalability, ease of use, reagent compatibility, after-sales support, or specialized applications like cell therapy or immunophenotyping.
Scope and Definition